Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 8:38:140.
doi: 10.11604/pamj.2021.38.140.25699. eCollection 2021.

Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report

Maryem Assamti  1 , Ramia Bougrine  1 , Nabila Ismaili  2 , Noha El Ouafi  1   2
Affiliations
Case Reports

Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report

Maryem Assamti et al. Pan Afr Med J. .

Abstract

Hypertrophic cardiomyopathy (HCM) is a common inherited cardiomyopathy, with an estimated prevalence of 1 in 500 people. Despite overall favorable outcomes with modern treatment and early diagnosis of disease, adverse complications could occur during times of physiological stress like pregnancy. Complications of HCM include sudden cardiac death, heart failure, and arrhythmia. We report the case of a 32-year-old pregnant woman with obstructive HCM, presenting with recurrent episodes of ventricular arrhythmia despite medical therapy. This case exhibits how close monitoring and proper management during pregnancy according to the latest recommendations, resulted in a successful and uneventful delivery.

Keywords: Hypertrophic cardiomyopathy; case report; pregnancy; sudden cardiac death.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
transthoracic echocardiography showing: A) a max instantaneous late peak gradient of 42 mmHg measured with continuous wave (CW) Doppler; B) a posterior wall thickness at 26 mm and a septum thickness at 17 mm measured on a parasternal long axis view
Figure 2
Figure 2
proposed algorithm for assessment and management of HCM during pregnancy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Authors/Task Force members. Elliot PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J. 2014 Oct 14;35(39):2733–79. - PubMed
    1. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardiomyopathy ». Mayo Clin Proc. 2005 Jun;80(6):739–44. - PubMed
    1. Regitz-Zagrosek V, Roos-Hessenlink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, Michele De Bonis, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal. 2018 Sep 7;39(34):3165–3241. - PubMed
    1. Maron MS, Hellawell JL, Lucove JC, Farzaneh-Far R, Olivotto I. Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States. Am J Cardiol. 2016 May 15;117(10):1651–1654. - PubMed
    1. Goland S, van Hagen IM, Elbaz-Greener G, Elkayam U, Shotan A, Merz WM, et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC) European Heart Journal. 2017 Sep;38(35):2683–2690. - PubMed

Publication types

MeSH terms